Rocket


Overview
Financials
News + Filings
Key Docs
Charts
Ownership
Insiders





Income Statement
Balance Sheet
Cash Flow Statement

Common Size IS
Op Efficiency
Credit Analysis

PLIANT THERAPEUTICS, INC. (PLRX)

Income Statement

Standardized | As Reported Annual | Quarterly | TTM
 
In millions, except per share itemsDec-31-22Dec-31-21Dec-31-20Dec-31-19Dec-31-18
   10-K10-K10-K10-KS-1/A
Revenue  9.77.641.857.1-24.4
            Revenue growth  27.9%-81.9%-26.7%-333.7% 
Operating expenses:       
Research and development  96.977.566.247.4 
General and administrative  39.927.617.310.96.5
Total operating expenses  136.9105.183.558.330.9
    Loss from operations  -127.2-97.5-41.6-1.2-30.9
            Operating margin  -1313.4%-1288.1%-99.6%-2.2% 
Interest and other income (expense), net  4.70.30.10.6 
    Net loss  -123.3-97.3-41.5-0.6-30.3
   
    Net loss attributable to common stockholders, basic  ($2.94)($2.71)($1.95)($4.22)($30.16)
    Net loss attributable to common stockholders, diluted  -123.3-97.3-41.5-6.90.0
   
Net loss per share, attributable to common stockholders - basic and diluted       
Net loss per share, attributable to common stockholders- basic(USD per share)  ($2.94)($2.71)($1.95)($4.22)($30.16)
Net loss per share, attributable to common stockholders- diluted (USD per share)  ($2.94)($2.71)($1.95)($4.22)($30.16)
   
Shares used in computing net loss per share attributable to common stockholders - basic and diluted       
Shares used in computing net loss per share attributable to common stockholders - basic  42.035.821.31.60.0
Shares used in computing net loss per share attributable to common stockholders - diluted  42.035.821.31.60.0
   
Comprehensive loss:       
    Net loss  -123.3-97.3-41.5-0.6-30.3
    Total other comprehensive loss  -1.8-0.20.00.0 
    Comprehensive loss  -125.1-97.4-41.6-0.6 

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy